hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
- PMID: 9288757
- DOI: 10.1016/s0092-8674(00)80538-3
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
Abstract
Telomerase, the ribonucleoprotein enzyme that elongates telomeres, is repressed in normal human somatic cells but is reactivated during tumor progression. We report the cloning of a human gene, hEST2, that shares significant sequence similarity with the telomerase catalytic subunit genes of lower eukaryotes. hEST2 is expressed at high levels in primary tumors, cancer cell lines, and telomerase-positive tissues but is undetectable in telomerase-negative cell lines and differentiated telomerase-negative tissues. Moreover, the message is up-regulated concomitant with the activation of telomerase during the immortalization of cultured cells and down-regulated during in vitro cellular differentiation. Taken together, these observations suggest that the induction of hEST2 mRNA expression is required for the telomerase activation that occurs during cellular immortalization and tumor progression.
Similar articles
-
Expression profile of the putative catalytic subunit of the telomerase gene.Cancer Res. 1998 Feb 15;58(4):622-5. Cancer Res. 1998. PMID: 9485011
-
Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence.Mol Carcinog. 1998 Jun;22(2):65-72. doi: 10.1002/(sici)1098-2744(199806)22:2<65::aid-mc1>3.0.co;2-j. Mol Carcinog. 1998. PMID: 9655250
-
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.Oncogene. 1998 Mar 5;16(9):1217-22. doi: 10.1038/sj.onc.1201882. Oncogene. 1998. PMID: 9528864
-
The significance of telomerase activation and cellular immortalization in human cancer.Mutagenesis. 2002 Nov;17(6):539-50. doi: 10.1093/mutage/17.6.539. Mutagenesis. 2002. PMID: 12435851 Review.
-
Telomerase regulation at the crossroads of cell fate.Cytogenet Genome Res. 2008;122(3-4):263-72. doi: 10.1159/000167812. Epub 2009 Jan 30. Cytogenet Genome Res. 2008. PMID: 19188695 Review.
Cited by
-
Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.Biochem Biophys Res Commun. 2012 Jun 15;422(4):561-7. doi: 10.1016/j.bbrc.2012.05.024. Epub 2012 May 16. Biochem Biophys Res Commun. 2012. PMID: 22609405 Free PMC article.
-
Small nucleolar RNAs in cancer.Biochim Biophys Acta. 2012 Aug;1826(1):121-8. doi: 10.1016/j.bbcan.2012.03.005. Epub 2012 Apr 3. Biochim Biophys Acta. 2012. PMID: 22498252 Free PMC article. Review.
-
Diet and aging.Oxid Med Cell Longev. 2012;2012:741468. doi: 10.1155/2012/741468. Epub 2012 Aug 13. Oxid Med Cell Longev. 2012. PMID: 22928085 Free PMC article. Review.
-
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.J Clin Pathol. 2005 Sep;58(9):911-4. doi: 10.1136/jcp.2004.024158. J Clin Pathol. 2005. PMID: 16126869 Free PMC article.
-
Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo.Mol Cell Biol. 2000 Nov;20(21):8178-84. doi: 10.1128/MCB.20.21.8178-8184.2000. Mol Cell Biol. 2000. PMID: 11027287 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials